EDESA BIOTECH, INC. Cash and Cash Equivalents, Period Increase (Decrease)
EDESA BIOTECH, INC. (EDSA) reported Cash and Cash Equivalents, Period Increase (Decrease) of $625.56 thousand for the 12-month period ending 2021-09-30, per its 10-K filed 2021-12-28.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-12-28
- EDESA BIOTECH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-09-30 was -$213.31K, a 113.56% decline year-over-year.
- EDESA BIOTECH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-06-30 was -$2.91M.
- EDESA BIOTECH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-03-31 was $4.66M, a 47.36% increase year-over-year.
- EDESA BIOTECH, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-12-31 was -$908.40K.
- EDESA BIOTECH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2021 was $625.56K, a 71.35% decline from fiscal 2020.
- EDESA BIOTECH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2020 was $2.18M.
- EDESA BIOTECH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$1.63M.
- EDESA BIOTECH, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$345.43K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 1 month | Cash and Cash Equivalents, Period Increase (Decrease) 1 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | -$213.31K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | -$3.13M derived: sum of 2 quarters · filed 2021-12-28 | $1.53M derived: sum of 3 quarters · filed 2021-12-28 | $625.56K 10-K · filed 2021-12-28 | ||||||
| 2021-06-30 | -$2.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $1.75M derived: sum of 2 quarters · filed 2021-08-13 | $838.88K 10-Q · filed 2021-08-13 | $2.41M derived: sum of 4 quarters · filed 2021-12-28 | ||||||
| 2021-03-31 | $4.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | $3.75M 10-Q · filed 2021-05-14 | $5.33M derived: sum of 3 quarters · filed 2021-12-28 | $3.98M derived: sum of 4 quarters · filed 2021-12-28 | ||||||
| 2020-12-31 | -$908.40K 10-Q · filed 2021-02-16 | $664.60K derived: sum of 2 quarters · filed 2021-12-28 | -$684.64K derived: sum of 3 quarters · filed 2021-12-28 | $2.48M derived: sum of 4 quarters · filed 2021-12-28 | ||||||
| 2020-09-30 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | $223.76K derived: sum of 2 quarters · filed 2021-12-28 | $3.39M derived: sum of 3 quarters · filed 2021-12-28 | $2.18M 10-K · filed 2021-12-28 | ||||||
| 2020-06-30 | -$1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $1.81M derived: sum of 2 quarters · filed 2021-08-13 | $610.11K 10-Q · filed 2021-08-13 | -$722.40K derived: sum of 4 quarters · filed 2021-08-13 | ||||||
| 2020-03-31 | $3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | $1.96M 10-Q · filed 2021-05-14 | $626.83K derived: sum of 3 quarters · filed 2021-05-14 | $3.95M derived: sum of 4 quarters · filed 2021-05-14 | ||||||
| 2019-12-31 | -$1.20M 10-Q · filed 2021-02-16 | -$2.54M derived: sum of 2 quarters · filed 2021-02-16 | $784.91K derived: sum of 3 quarters · filed 2021-02-16 | $459.95K derived: sum of 4 quarters · filed 2021-02-16 | ||||||
| 2019-09-30 | -$1.33M derived: 10-K 9 month − 10-Q 6 month · filed 2020-12-07 | $1.99M derived: sum of 2 quarters · filed 2020-12-07 | $1.66M 10-K · filed 2020-12-07 | $1.30M derived: sum of 4 quarters · filed 2020-12-07 | ||||||
| 2019-06-30 | $3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-12 | $3.00M 10-Q · filed 2019-08-14 | $2.63M 10-Q · filed 2020-08-12 | $1.04M derived: sum of 4 quarters · filed 2020-08-12 | ||||||
| 2019-03-31 | -$324.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | -$688.09K 10-Q · filed 2020-05-15 | $3.46M 10-Q · filed 2019-05-08 | -$2.28M derived: sum of 3 quarters · filed 2020-05-15 | $244.42K derived: sum of 4 quarters · filed 2020-05-15 | |||||
| 2018-12-31 | -$363.13K 10-Q · filed 2020-02-13 | $3.14M 10-Q · filed 2019-02-05 | -$1.96M derived: sum of 2 quarters · filed 2020-02-13 | $569.38K derived: sum of 3 quarters · filed 2020-02-13 | -$1.63M 10-KT · filed 2019-12-12 | |||||
| 2018-09-30 | -$1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $932.51K derived: sum of 2 quarters · filed 2018-11-30 | -$144.15K derived: sum of 3 quarters · filed 2019-05-08 | -$345.43K 10-K · filed 2018-11-30 | ||||||
| 2018-06-30 | $2.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | -$1.06M 10-Q · filed 2019-08-14 | $1.25M 10-Q · filed 2018-08-08 | $2.17M derived: sum of 4 quarters · filed 2019-05-08 | ||||||
| 2018-03-31 | -$1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | -$1.28M 10-Q · filed 2019-05-08 | -$354.35K derived: sum of 3 quarters · filed 2019-05-08 | -$1.31M derived: sum of 4 quarters · filed 2019-05-08 | ||||||
| 2017-12-31 | -$201.28K 10-Q · filed 2019-02-05 | $722.31K derived: sum of 2 quarters · filed 2019-02-05 | -$231.55K derived: sum of 3 quarters · filed 2019-02-05 | -$1.52M derived: sum of 4 quarters · filed 2019-02-05 | ||||||
| 2017-09-30 | $923.59K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | -$30.27K derived: sum of 2 quarters · filed 2018-11-30 | -$1.31M derived: sum of 3 quarters · filed 2018-11-30 | -$2.85M 10-K · filed 2018-11-30 | ||||||
| 2017-06-30 | -$953.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | -$2.24M derived: sum of 2 quarters · filed 2018-08-08 | -$3.77M 10-Q · filed 2018-08-08 | -$1.14M derived: sum of 4 quarters · filed 2018-08-08 | ||||||
| 2017-03-31 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-07 | -$2.82M 10-Q · filed 2018-05-07 | -$185.98K derived: sum of 3 quarters · filed 2018-05-07 | -$1.36M derived: sum of 4 quarters · filed 2018-05-07 | ||||||
| 2016-12-31 | -$1.53M 10-Q · filed 2018-02-07 | $1.10M derived: sum of 2 quarters · filed 2018-02-07 | -$76.32K derived: sum of 3 quarters · filed 2018-02-07 | $2.00M derived: sum of 4 quarters · filed 2018-02-07 | ||||||
| 2016-09-30 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $1.46M derived: sum of 2 quarters · filed 2017-12-01 | $3.53M derived: sum of 3 quarters · filed 2017-12-01 | $3.46M 10-K · filed 2017-12-01 | ||||||
| 2016-06-30 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $899.65K derived: sum of 2 quarters · filed 2017-08-09 | $831.70K 10-Q · filed 2017-08-09 | -$360.06K derived: sum of 4 quarters · filed 2017-12-01 | ||||||
| 2016-03-31 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-09 | $2.01M 10-Q · filed 2017-05-09 | $814.47K derived: sum of 3 quarters · filed 2017-12-01 | -$175.29K derived: sum of 4 quarters · filed 2017-12-01 | ||||||
| 2015-12-31 | -$67.95K 10-Q · filed 2017-02-06 | -$1.26M derived: sum of 2 quarters · filed 2017-12-01 | -$2.25M derived: sum of 3 quarters · filed 2017-12-01 | -$3.87M derived: sum of 4 quarters · filed 2017-12-01 | ||||||
| 2015-09-30 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | -$2.18M derived: sum of 2 quarters · filed 2017-12-01 | -$3.81M derived: sum of 3 quarters · filed 2017-12-01 | -$4.81M 10-K · filed 2017-12-01 | ||||||
| 2015-06-30 | -$989.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | -$2.61M derived: sum of 2 quarters · filed 2016-08-09 | -$3.62M 10-Q · filed 2016-08-09 | -$3.61M 10-Q · filed 2015-08-10 | ||||||
| 2015-03-31 | -$1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09 | -$2.63M 10-Q · filed 2016-05-09 | -$2.62M 10-Q · filed 2015-05-11 | |||||||
| 2014-12-31 | -$1.01M 10-Q · filed 2016-02-08 | -$1.01M 10-Q · filed 2015-02-09 | ||||||||
| 2014-09-30 | $345.37K 10-K · filed 2016-12-14 | $342.55K 10-Q · filed 2015-02-09 | ||||||||
| 2014-08-31 | $563.20K 10-K · filed 2016-12-14 | $5.57M 10-K · filed 2014-11-21 | ||||||||
| 2014-06-30 | -$982.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | -$2.28M derived: sum of 2 quarters · filed 2015-08-10 | -$1.04M 10-Q · filed 2015-08-10 | |||||||
| 2014-03-31 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | -$53.39K 10-Q · filed 2015-05-11 | ||||||||
| 2013-12-31 | $1.25M 10-Q · filed 2015-02-09 | |||||||||
| 2013-09-30 | $7.62M 10-Q · filed 2015-02-09 | |||||||||
| 2013-08-31 | $6.86M 10-K · filed 2015-12-14 | |||||||||
| 2012-08-31 | -$3.15M 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |